| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86d1f90da4ab5bc8e2605a3d72c75bf8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c23119505993c411d2b9b1ce1d78ee45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0ff9245316d63f4883fcd112618fee6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-1019 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 |
| filingDate |
2001-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a2260601b2ecdfd99a202cf5893f8e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d60a3412b98ef7a4da84d3c296c578ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158d0e09c2546d7895e09b982838aeda |
| publicationDate |
2002-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2177802-C1 |
| titleOfInvention |
Tetrapeptide regulating prostate function, pharmacological agent based on thereof and method of its using |
| abstract |
FIELD: medicine, peptides. SUBSTANCE: invention proposes biologically active compound of the general formula: Lys-Glu-Asp-Pro eliciting ability regulating functions of prostate and pharmacological agent containing effective dose of tetra- -peptide of the formula Lys-Glu- Asp-Pro or its salts as an active component and designated for parenteral administration. Method of regulation of prostate function involves curative administration to patient the pharmacological agent in doses 0.01-100 mcg/kg of body mass at least one time per a day for period that is necessary for attainment of therapeutic effect. Agent shows ability to regulate functions of prostate, normalize metabolism and microcirculation in prostate, it shows antioxidant effect and therefore this agent can be used for regulation of prostate function. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 9 cl, 4 tbl, 7 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2675624-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014162190-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2640931-C1 |
| priorityDate |
2001-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |